EULAR recommendations for the management of antiphospholipid syndrome in adults

Cited by (1,254)

Items 301–400 of 1,254

1. Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders
   Saion Chatterjee, John David Pauling · 2020 · Clinical Rheumatology
2. Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
   Snjezana Janjetovic, Lennart Beckmann, Katharina Holstein, Christina Charlotte Rolling, Benjamin Thiele, Philippe Schafhausen, Gerhard Schön, Carsten Bokemeyer, Florian Peter Länger, Minna Voigtlaender · 2020 · Thrombosis Research
3. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy
   Stefano Celotto, Nicola Veronese, Mario Barbagallo, Francesca Ometto, Lee Smith, Shahina Pardhan, Yvonne Barnett, Petre Cristian Ilie, Pınar Soysal, Erik Lagolio et al. · 2020 · International Journal of Infectious Diseases
4. Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients
   Maddalena Larosa, Véronique Le Guern, Nathalie Morel, Mériem Belhocine, Amelia Ruffatti, Nicolas Martin Silva, Romain Paule, Luc Mouthon, Michel Dreyfus, J.C. Pietté et al. · 2021 · Arthritis Research & Therapy
5. Antiphospholipid antibodies and idiopathic infertility
   Flavia Del Porto, Susanna Ferrero, Noemi Cifani, Giorgio Sesti, Maria Proietta · 2022 · Lupus
6. Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients
   Cécile Yelnik, Claire Martin, Emmanuel Ledoult et al. · 2022 · Lupus
7. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing
   Julien Cabo, Laure Morimont, Justine Baudar, Maïté Guldenpfennig, Hugues Jacqmin, Reza Soleimani, Thomas Lecompte, Jonathan Douxfils, François Mullier · 2022 · International Journal of Laboratory Hematology
8. Antithrombotic therapy in antiphospholipid syndrome with arterial thrombosis: a systematic review and network meta-analysis
   Tanawat Attachaipanich, Aimpat Aungsusiripong, Pokpong Piriyakhuntorn, Sasinee Hantrakool, Ekarat Rattarittamrong, Thanawat Rattanathammethee, Adisak Tantiworawit, Lalita Norasetthada, Chatree Chai‐Adisaksopha · 2023 · Frontiers in Medicine
9. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
   Hannah Cohen, David John Werring, Arvind Chandratheva, Prabal Mittal, Katrien M.J. Devreese, David Alan Isenberg, Zahir Amoura, DANIELI CASTRO OLIVEIRA DE ANDRADE, Hela Baccouche, Neil Baldwin et al. · 2023 · Journal of Thrombosis and Haemostasis
10. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children
    Zahir Amoura, Brigitte Bader‐Meunier, Claire Bal dit Sollier, Alexandre Bélot, Y. Benhamou, H. Bézanahary, Fleur Cohen Aubart, Nathalie Costedoat-Chalumeau, Luc Darnige, Ludovic O. Drouet et al. · 2023 · La Revue de Médecine Interne
11. Update on antiphospholipid syndrome
    Maria G. Tektonidou · 2024 · Lara D. Veeken
12. Antiphospholipidsyndrom
    Christof Specker, Rebecca Fischer‐Betz, Thomas Dörner · 2020 · Zeitschrift für Rheumatologie
13. Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods study
    Lindsay Bearne, Julie Bieles, Sofia Georgopoulou et al. · 2020 · Lupus
14. Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome
    Sebastián Udry, Stephanie Morales-Pérez, Cristina C. Belizna, Federico Manuel Aranda, Enrique Esteve‐Valverde, Silvia D. Perés Wingeyer, Diego S Fernández-Romero, José Omar Latino, Gabriela Fernanda De Larrañaga, Jaume Alijotas‐Reig · 2022 · Lupus
15. Role of Antiplatelets and Anticoagulation Therapies in Pregnancy
    K Varghese Zachariah, Su Yuan, Maria Teresa DeSancho, Inna V. Landres, Harsimran Sachdeva Singh · 2024 · Journal of Clinical Medicine
16. Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome
    Qing-Nan Zhu, Xingying Qi, Shu-Wei Ren, Yuye Li, Ze-Wen Yan, Yuling Sun, Yan Shi, Qing-Si Wen, Ming‐Shiou Wu, Dapeng Wang · 2025 · Frontiers in Immunology
17. PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
    Rohan Willis, Thomas C. R. McDonnell, Charis Pericleous · 2022 · Frontiers in Immunology
18. Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
    Stanley Niznik, Micha J. Rapoport, Orly Hamburger Avnery, Aharon Lubetsky, Ronen Shavit, Martin H. Ellis, Nancy Agmon‐Levin · 2022 · Frontiers in Pharmacology
19. Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms
    Jina Yeo, Inpyeong Hwang, Chul‐Ho Sohn · 2022 · Frontiers in Medicine
20. Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrual
    Pedro Gaspar, Prabal Mittal, Hannah Cohen, David Alan Isenberg · 2024 · Research and Practice in Thrombosis and Haemostasis
21. Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests
    Marie Ottavi, Pierre A. Toulon, Barbara Casolla, Nihal Martis · 2024 · Frontiers in Immunology
22. Recurrent miscarriage and low-titer antiphospholipid antibodies
    Jian Chen, Jing Yue, Lu Yu, Ting Li, Xue Li, Jianyu Zhang · 2024 · Clinical Rheumatology
23. Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation
    Brianna R. Bakow, Lisa R. Yanek, Mark Andrew Crowther · 2024 · Thrombosis Research
24. Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study
    Martyna Sikorska, Jakub Chmiel, Elżbieta Papuga-Szela, Elżbieta Broniatowska, Anetta Undas · 2024 · Journal of Cardiovascular Pharmacology
25. Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications—a population-based study
    Ariel Katherine Rhein, Anat Rabinovich, Ran Abuhasira, Shir Lubaton-Barshishat, Offer Erez · 2024 · Research and Practice in Thrombosis and Haemostasis
26. Antiphospholipid antibody testing
    Savino Sciascia, Barbara Montaruli, Maria Giaele Infantino · 2024 · Medicina Clínica
27. Direct Oral Anticoagulants: Quick Primer on When to Use and When to Avoid
    Antoine Bejjani, Behnood Bikdeli · 2024 · Thrombosis and Haemostasis
28. Warfarin and heparin monitoring in antiphospholipid syndrome
    Prabal Mittal, Zara Sayar, Hannah Cohen · 2024 · Hematology
29. Role of placental inflammatory mediators and growth factors in patients with rheumatic diseases with a focus on systemic sclerosis
    Francesca Motta, Veronica Codullo, Véronique Laure Ramoni et al. · 2020 · Lara D. Veeken
30. Classification Criteria and Clinical Practice Guidelines for Rheumatic Diseases
    Rola Hassan, Hanan Mohammed Faruqui, Reem Alquraa · 2021 · Springer eBooks
31. The high prevalence of abnormal magnetic resonance imaging findings in non-neuropsychiatric patients with persistently positive anti-phospholipid antibodies
    Liyan Wan, Tingting Liu, Tongtong Chen, Huihui Chi, Zhuochao Zhou, Zihan Tang, Qiongyi Hu, Jialin Teng, Yue Sun, Honglei Liu et al. · 2021 · Rheumatology
32. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies’ types and titers—cross-sectional study of Serbian cohort
    Aleksandra Djoković, Ljudmila Stojanovich, Nataša Stanisavljević, Sandra Djokic, Branka F. Filipović, Predrag Matić, Milomir Milanović, Svetlana R. Apostolovic, Jovica Saponjski · 2022 · Clinical Rheumatology
33. Refractory antiphospholipid antibody syndrome–induced thrombocytopaenia successfully treated with belimumab
    Riku Yoshizuka, Hisanori Hasegawa, Mari Kamiya · 2022 · Lupus
34. Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome
    Rafid Mustafa · 2022 · Current Neurology and Neuroscience Reports
35. Adaptive Learning Based on Artificial Intelligence to Overcome Student Academic Inequalities
    Faridul Ansor, Nur Aisyah Zulkifli, Dwi Susi Miftakhul Jannah, Aldila Krisnaresanti · 2023 · Journal of Social Science Utilizing Technology
36. Treatment of Vascular Thrombosis in Antiphospholipid Syndrome: An Update
    Lida Kalmanti, Edelgard Lindhoff‐Last · 2020 · Hämostaseologie
37. Treatment of thrombotic antiphospholipid syndrome in adults and children
    Jacqueline A. Madison, Alí Duarte‐García, Yu Zuo, Jason S. Knight · 2020 · Current Opinion in Rheumatology
38. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?
    Ilenia Lorenza Calcaterra, Antonella Tufano, Roberta Lupoli, Gabriella Iannuzzo, Giacomo Emmi, Matteo Nicola Dario Di Minno · 2020 · Polskie Archiwum Medycyny Wewnętrznej
39. Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
    Minerva Codruța Bădescu, Elena Rezuş, Manuela Ciocoiu, Oana Viola Bădulescu, Lăcrămioara Ionela Butnariu, Diana Popescu, Ioana Bratoiu, Ciprian Rezuș · 2022 · International Journal of Molecular Sciences
40. Aportaciones del registro de lupus de la Sociedad Española de Reumatología (RELESSER) al conocimiento del lupus eritematoso sistémico en España
    Íñigo Rúa-Figueroa Fernández de Larrinoa, José María Pego‐Reigosa, J. López-Longo et al. · 2020 · Reumatología Clínica
41. Recurrent Mural Thrombosis of the Ascending Aorta in a Patient with Antiphospholipid Syndrome
    Ryohei Otsuka, Shunei Saito, Toshikuni Yamamoto · 2022 · Annals of Vascular Diseases
42. Intravenous immunoglobulin treatment for obstetric antiphospholipid syndrome refractory to conventional therapy: A single-arm, open-labelled multicentre clinical trial
    Kayoko Kaneko, Seiji Tsutsumi, Daisuke Fujita, Mayumi Sugiura‐Ogasawara, Nobuaki Mitsuda, Keiichi Matsubara, Tatsuya Atsumi, Eisuke Inoue, Tetsuya Takimoto, Atsuko Murashima · 2023 · Modern Rheumatology
43. Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials
    Josefine Bak Højer Adelhelm, Robin Christensen, Gustavo Guimarães Moreira Balbi, Anne Voss · 2023 · Lupus Science & Medicine
44. Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review
    Massimiliano Castellazzi, Raffaella Candeloro, Maura Pugliatti, Marcello Govoni, Ettore Silvagni, Alessandra Bortoluzzi · 2024 · Diagnostics
45. H3K4me3‐Mediated FOXJ2/SLAMF8 Axis Aggravates Thrombosis and Inflammation in β2GPI/Anti‐β2GPI‐Treated Monocytes
    Yuan Tan, Jiao Qiao, Shuo Yang, Hongchao Liu, Qingchen Wang, Qi Liu, Weimin Feng, Liyan Cui · 2024 · Advanced Science
46. Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review
    Mathilde Lambert, Alexandre Brodovitch, Jean‐Louis Mège, Daniel Bertin, Nathalie Bardin · 2024 · Autoimmunity Reviews
47. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications
    Diana Castillo‐Martínez, Mauricio Mora-Ramírez, Raúl Molina-Sánchez · 2024 · Clinical Rheumatology
48. Sex‐influence on the time in therapeutic range (TTR) during oral anticoagulation with coumarin derivatives: Systematic review and meta‐analysis
    Catiane Costa Viana, Marcus Fernando da Silva Praxedes, Waleska Jaclyn Freitas Nunes de Sousa, Frederico Bartolazzi, Mayara Sousa Vianna, José Luiz Padilha da Silva, Maria Auxiliadora Parreiras Martins · 2021 · British Journal of Clinical Pharmacology
49. Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers
    Fadi Hassan, Mohammad Ebrahim Naffaa, Amir Saab, Chaim Putterman · 2022 · Brain Sciences
50. Management and outcomes of women with antiphospholipid syndrome during pregnancy
    Jacqueline J. Tao, Sanjana Adurty, Debra D’Angelo, Maria Teresa DeSancho · 2023 · Journal of Thrombosis and Thrombolysis
51. IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
    Savino Sciascia, Irene Cecchi, Massimo Radin, Elena Rubini, Ana Suárez, Dario Roccatello, Javier Rodríguez‐Carrio · 2019 · Frontiers in Medicine
52. Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome
    Daniel Álvarez, Carolina Rúa, Ángela P. Cadavid J · 2021 · Seminars in Thrombosis and Hemostasis
53. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update
    Xiaodong Li, Abdullah Shopit, Jingmin Wang · 2021 · Archives of Gynecology and Obstetrics
54. Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist
    Juan Camilo Santacruz, Marta Juliana Mantilla, I. A. Rincón Rueda, Sandra Pulido, Gustavo Rodríguez, John Darío Londoño · 2022 · Cureus
55. Direct oral anticoagulants versus warfarin in patients with single antibody‐positive anti‐phospholipid syndrome
    Angela Liu, Karishma Vijay Rupani, Leonard Naymagon · 2022 · European Journal Of Haematology
56. Influence of Antiphospholipid Antibody-Associated Thrombophilia on the Risk of Preterm Birth: A Systematic Review
    Olivera Iordache, Doru Mihai Anastasiu, Manaswini Kakarla, Ayesha Ali, Felix Bratosin, Radu Neamțu, Cătălin Dumitru, Flavius Olaru, Izabella Erdelean, Angelica Gherman et al. · 2023 · Journal of Clinical Medicine
57. Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban
    Romain Stammler, Paul Legendre, P. Cacoub, Philippe Blanche, J.C. Pietté, Nathalie Costedoat-Chalumeau · 2020 · Lupus
58. Prevalence and factors associated with high-risk thrombophilia: a single-center cross-sectional study of 3550 patients at a tertiary Thrombosis Centre in Switzerland
    Shabnam Najaf Zadeh, Fabienne Schmidli, Katarzyna Aleksandra Jalowiec · 2025 · Research and Practice in Thrombosis and Haemostasis
59. Anticoagulantes de acción directa en el síndrome antifosfolípido. Revisión sistemática
    José Antonio Girón-Ortega, J.A. Girón González · 2023 · Medicina Clínica
60. Risk factors and recurrent thrombosis in primary antiphospholipid syndrome
    Fariza A. Cheldieva, Anastasiia A. Shumilova, Mariya V. Cherkasova, Svetlana I. Glukhova, Aleksander M. Lila, Evgeny Lvovich Nasonov, Tatiana Magomedalievna Reshetnyak · 2023 · Exploration of Immunology
61. Risk prediction model based on machine learning for predicting miscarriage among pregnant patients with immune abnormalities
    Yue Wu, Xixuan Yu, Mengting Li · 2024 · Frontiers in Pharmacology
62. Antiphospholipid syndrome in children
    Mojca Zajc Avramovič, Tadej Avčin · 2024 · Best Practice & Research Clinical Rheumatology
63. Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies
    Katrien M.J. Devreese · 2024 · Seminars in Thrombosis and Hemostasis
64. Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities
    Fatemeh Askarizadeh, Sercan Karav, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2024 · Pharmacological Reports
65. Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria
    Marion Mercier, Alain Lescoat, Morgane Pierre‐Jean, Erwan Dumontet, Maëla Le Lous, Nicolas Belhomme · 2024 · Journal of Clinical Medicine
66. Can we use NOACS in APS?
    Hagit Peleg, Yaakov Naparstek, Francesca Regola, Anǵela Tincani, Vittorio Pengo, Gentian Denas · 2019 · Autoimmunity Reviews
67. Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a case of pembrolizumab associated catastrophic antiphospholipid syndrome?
    E M W Mintjens-Jager, Martin Vos, Gürsah Kats‐Ugurlu, Geke A.P. Hospers, Abraham Rutgers, Matijs van Meurs · 2020 · SAGE Open Medical Case Reports
68. Is the presence of antiphospholipid antibodies a poor prognostic factor for patients with hemolysis, elevated liver enzymes, and low platelet count syndrome?
    Mathilde Pécourt, Cécile Yelnik, Louise Ghesquière et al. · 2021 · American Journal of Obstetrics and Gynecology
69. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines
    Gilberto Pires da Rosa, Ignasi Rodríguez‐Pintó, Ricard Cervera, Gerard Espinosa · 2021 · Expert Review of Hematology
70. Pr-AKI: Acute Kidney Injury in Pregnancy – Etiology, Diagnostic Workup, Management
    Florian Gunnar Scurt, Ronnie Morgenroth, Katrin Bose, Peter Rene Mertens, Christos Chatzikyrkou · 2022 · Geburtshilfe und Frauenheilkunde
71. Efficacy and Safety of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis
    Keerthi Gullapalli, Rohan Madhu Prasad, Abdullah K. Al-Abcha · 2022 · Cureus
72. Low-cost zeolitic carriers for delivery of hydroxychloroquine immunomodulatory agent with antiviral activity
    Anna Olejnik, Rafał Panek, Jarosław Madej · 2022 · Microporous and Mesoporous Materials
73. Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome
    Meige Liu, Gongming Li, Xiaodong Song, Yangyi Fan, Chun Li · 2023 · Scientific Reports
74. Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sjögren’s syndrome: a retrospective cohort study
    Juan J. Fierro, Jelmer Riemer Prins, Gwenny M. P. J. Verstappen · 2023 · RMD Open
75. Risk factors of first thrombosis in obstetric antiphospholipid syndrome
    Liang Luo, Qingmeng Cai, Xiangjun Liu, Yuke Hou, Chun Li · 2024 · Lupus Science & Medicine
76. Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome
    Nadine Müller-Calleja, Wolfram Ruf, Karl Johannes Lackner · 2024 · Critical Reviews in Clinical Laboratory Sciences
77. Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
    Gustavo Guimarães Moreira Balbi, Marcelo de Souza Pacheco, Odirlei André Monticielo, Andreas Funke, Adriana Danowski, Mittermayer Barreto Santiago, Henrique Luiz Staub, Jozélia Rêgo, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2020 · Revista Brasileira de Reumatologia
78. Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester
    Cecilia Beatrice Chighizola, Savino Sciascia, Laura Andréoli, Pier Luigi Meroni · 2020 · Autoimmunity Reviews
79. Clinical value of amyloid-beta1-40 as a marker of thrombo-inflammation in antiphospholipid syndrome
    Maria G. Tektonidou, Evrydiki Kravvariti, Nikolaos I. Vlachogiannis, Georgios A. Georgiopoulos, Aimilia Mantzou, Petros Paul Sfikakis, Konstantinos Stellos, Kimon S. Stamatelopoulos · 2020 · Lara D. Veeken
80. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin
    George Markousis‐Mavrogenis, Petros Paul Sfikakis, Sophie I. Mavrogeni, Maria G. Tektonidou · 2020 · Clinical Rheumatology
81. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
    Christian Albert Devaux, Laurence Camoin‐Jau, Jean‐Louis Mège, Didier Raoult · 2021 · Journal of Microbiology Immunology and Infection
82. Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients
    Mireia Constans, Raquel Santiago, Lidia Jimenez, Cristina Motlló, R. J. F. Lopez, Jaume Trapé, Joan Carles Reverter, Albert Altés · 2021 · Thrombosis Research
83. Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
    Shreya Arora, Shaalina Nair, Rishab Rajendra Prabhu, Chaithanya Avanthika, Sharan Jhaveri, Shilpa Samayam, Maanya Rajasree Katta, Pahel Agarwal · 2021 · Cureus
84. Current status and role of antiphospholipid antibody testing in cryptogenic stroke
    Wookjin Yang, Min Kyoung Kang, Sue Young Ha, Dong‐Wan Kang, Jeonghoon Bae, Eung‐Joon Lee, Han‐Yeong Jeong, Jeong‐Min Kim, Keun‐Hwa Jung, Seung‐Hoon Lee · 2021 · European Journal of Neurology
85. COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study
    Haoyu Pan, Zihan Tang, Jialin Teng, Yue Sun, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Qiongyi Hu, Huihui Chi et al. · 2022 · Rheumatology
86. Pathophysiology of Placenta in Antiphospholipid Syndrome
    Anca Vasilica Bobirca, Ana Dumitrache, Cristina Alexandru, Anca Florescu, George Ciobotaru, Florin Teodor BOBIRCA, Romina‐Marina Sima, Cristian Viorel Poalelungi, Mihai Bojincă, I. Ancuta · 2022 · Physiologia
87. How to approach acute thrombosis and thrombocytopenia
    Jeremy Schofield, Cheng‐Hock Toh · 2023 · Clinical Medicine
88. A retrospective study on IVF/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: Effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment
    Yuan Zhang, Xue Song, Xinru Xia, Jing Wang, Yi Qian, Chun Yuan, Yundong Mao, Feiyang Diao, Jiayin Liu, Xiang Ma · 2022 · Journal of Reproductive Immunology
89. Chloroquine drug and Graphene complex for treatment of COVID-19
    Saeedeh Mohammadi, Mohammad Esmailpour, Mina Mohammadi · 2020
90. Warfarin Is the Preferred Therapy for Patients With Thrombotic APS
    Mark Andrew Crowther, Aubrey E. Jones, Daniel M. Witt · 2022 · Journal of the American College of Cardiology
91. The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies
    Giorgia Grosso, Kerstin Sandholm, Aleksandra Antovič et al. · 2021 · Thrombosis and Haemostasis
92. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
    Giorgia Ingrid Gozzoli, Elda Piovani, Beatrice Negri, Margaret Mascherpa, Rossana Orabona, Cristina Zanardini, Sonia Zatti, Silvia Piantoni, Maria Grazia Lazzaroni, Cesare Tomasi et al. · 2022 · Frontiers in Immunology
93. Spontaneous Adrenal Hemorrhage with Mild Hypoadrenalism in a Patient Anticoagulated with Apixaban for Antiphospholipid Syndrome: A Case Report and Literature Review
    Jia Wei Tan, Anant Shukla, Jiun‐Ruey Hu, Sachin K. Majumdar · 2022 · Case Reports in Endocrinology
94. Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch
    Georges El Hasbani, Imad W. Uthman · 2023 · Lupus
95. Impact of Antiphospholipid Syndrome on Reproductive Outcomes: Current Insights and Management Approaches
    Lauren He, Catherine A. Sims · 2024 · Seminars in Reproductive Medicine
96. Prevalence and Risk Factors of Acute Ischemic Stroke in Patients with Antiphospholipid Syndrome: A Retrospective Monocenter Analysis
    Paschalis Evangelidis, Nikolaos Kotsiou, Panagiotis Kalmoukos et al. · 2025 · Journal of Cardiovascular Development and Disease
97. Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus
    Inês Rueff Rato, Ana Rita Barbosa, David João Afonso · 2021 · Lupus
98. Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
    Annabel Schulz, Eva Maria Herrmann, Olivia Ott, Edelgard Lindhoff‐Last · 2022 · Journal of Clinical Medicine
99. Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
    Nataša Stanisavljević, Ljudmila Stojanovich, Aleksandra Djoković, B. Todic, Violeta Dopsaj, Jovica Saponjski, Dušan Šaponjski, Olivera Marković, Cristina C. Belizna, Marija D. Zdravkovic et al. · 2022 · International Journal of Molecular Sciences
100. Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
     Núria Baños, Aleida Susana Castellanos Gutierrez, Giuseppe Barilaro, F. Figueras, Gema Maria Lledó, Marta Santana, Gerard Espinosa · 2022 · Journal of Clinical Medicine